Voltage Capital
The most significant advances in science and engineering emerge not from within the mainstream of a field but at the boundaries between disciplines. Voltage Capital was established with the vision that nontraditional solutions and unconventional individuals will drive the future of Private Equity. To that end Voltage has recruited a diverse and motivated group of world class entrepreneurs and scientists and commissioned them with the task of exploring emerging technology in order to discover, harvest and commercialize new products.
Voltage’s strength is in its ability to add dimensionality beyond the flat and passive analysis of an invention or business model by actively contributing, building upon or redirecting the seed idea. The advantage of being able to actively collaborate both scientifically and financially places Voltage Capital in a unique and highly independent position.
Voltage Capital is thus able to engage in a profoundly richer and broader range of projects generally untenable for standard investment funds. By combining the art of scientific discovery with the creativity of entrepreneurship and the experience of sound investing Voltage creates a special “evolutionary” advantage which results in unprecedented investment opportunities.
Teva
One of my first investments in Pharmaceuticals was with Teva, the largest generic drug company in the world. I acquired the shares in a direct transaction with Robert Maxwell.